Clinical Trial Update: Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers [Phase 2]

View source ↗

Summary

Phase 2 trial investigating aspirin and zileuton effects on biomarker expression in nasal tissue of current smokers with tobacco use disorder; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Aspirin (Aspirin)
• Zileuton (zileuton)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-03-23